Literature DB >> 10391907

Activation of the cAMP-specific phosphodiesterase PDE4D3 by phosphorylation. Identification and function of an inhibitory domain.

J Lim1, G Pahlke, M Conti.   

Abstract

Splicing variants of type 4 phosphodiesterases (PDE4) are regulated by phosphorylation. In these proteins, a conserved region is located between the amino-terminal domain, which is the target for phosphorylation, and the catalytic domain. Previous studies have indicated that nested deletions encompassing this region cause an increase in catalytic activity, suggesting this domain exerts an inhibitory constraint on catalysis. Here, we have further investigated the presence and function of this domain. A time-dependent increase in hydrolytic activity was observed when PDE4D3 from FRTL-5 cells was incubated with the endoproteinase Lys-C. The activation was abolished by protease inhibitors and was absent when a phosphorylated enzyme was used. Western blot analysis with PDE4D-specific antibodies indicated the Lys-C treatment separates the catalytic domain of PDE4D3 from the inhibitory domain. Incubation with antibodies recognizing an epitope within this domain caused a 3- to 4-fold increase in activity of native or recombinant PDE4D3. Again, PDE activation by these antibodies had properties similar to, and not additive with, the activation by protein kinase A phosphorylation. An interaction between the inhibitory domain and both regulatory and catalytic domains of PDE4D3 was detected by the yeast two-hybrid system. Mutations of Ser54 to Ala in the regulatory domain decreased or abolished this interaction, whereas mutations of Ser54 to the negatively charged Asp strengthened it. These data strongly support the hypothesis that an inhibitory domain is present in PDE4D and that phosphorylation of the regulatory domain causes activation of the enzyme by modulating the interaction between inhibitory and catalytic domains.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10391907     DOI: 10.1074/jbc.274.28.19677

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  26 in total

1.  mAKAP assembles a protein kinase A/PDE4 phosphodiesterase cAMP signaling module.

Authors:  K L Dodge; S Khouangsathiene; M S Kapiloff; R Mouton; E V Hill; M D Houslay; L K Langeberg; J D Scott
Journal:  EMBO J       Date:  2001-04-17       Impact factor: 11.598

2.  Absence of muscarinic cholinergic airway responses in mice deficient in the cyclic nucleotide phosphodiesterase PDE4D.

Authors:  G Hansen; S Jin; D T Umetsu; M Conti
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-06       Impact factor: 11.205

3.  Activation of phosphodiesterase 5 and inhibition of guanylate cyclase by cGMP-dependent protein kinase in smooth muscle.

Authors:  K S Murthy
Journal:  Biochem J       Date:  2001-11-15       Impact factor: 3.857

4.  Short-term regulation of PDE4 activity.

Authors:  V Manganiello
Journal:  Br J Pharmacol       Date:  2002-06       Impact factor: 8.739

5.  Putting the lid on phosphodiesterase 4.

Authors:  Miles D Houslay; David R Adams
Journal:  Nat Biotechnol       Date:  2010-01       Impact factor: 54.908

6.  The upstream conserved regions (UCRs) mediate homo- and hetero-oligomerization of type 4 cyclic nucleotide phosphodiesterases (PDE4s).

Authors:  Moses Xie; Brigitte Blackman; Colleen Scheitrum; Delphine Mika; Elise Blanchard; Tao Lei; Marco Conti; Wito Richter
Journal:  Biochem J       Date:  2014-05-01       Impact factor: 3.857

7.  Genomic and functional characterizations of phosphodiesterase subtype 4D in human cancers.

Authors:  De-Chen Lin; Liang Xu; Ling-Wen Ding; Arjun Sharma; Li-Zhen Liu; Henry Yang; Patrick Tan; Jay Vadgama; Beth Y Karlan; Jenny Lester; Nicole Urban; Michèl Schummer; Ngan Doan; Jonathan W Said; Hongmao Sun; Martin Walsh; Craig J Thomas; Paresma Patel; Dong Yin; Daniel Chan; H Phillip Koeffler
Journal:  Proc Natl Acad Sci U S A       Date:  2013-03-27       Impact factor: 11.205

8.  Interaction with receptor for activated C-kinase 1 (RACK1) sensitizes the phosphodiesterase PDE4D5 towards hydrolysis of cAMP and activation by protein kinase C.

Authors:  Rebecca J Bird; George S Baillie; Stephen J Yarwood
Journal:  Biochem J       Date:  2010-11-15       Impact factor: 3.857

9.  An evolutionary analysis of cAMP-specific Phosphodiesterase 4 alternative splicing.

Authors:  Keven R Johnson; Jessie Nicodemus-Johnson; Robert S Danziger
Journal:  BMC Evol Biol       Date:  2010-08-11       Impact factor: 3.260

10.  RACK1 and β-arrestin2 attenuate dimerization of PDE4 cAMP phosphodiesterase PDE4D5.

Authors:  Graeme B Bolger
Journal:  Cell Signal       Date:  2015-08-06       Impact factor: 4.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.